H Staudinger
Overview
Explore the profile of H Staudinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akinlade B, Guttman-Yassky E, de Bruin-Weller M, Simpson E, Blauvelt A, Cork M, et al.
Br J Dermatol
. 2019 Mar;
181(3):459-473.
PMID: 30851191
Background: Dupilumab blocks the shared receptor component for interleukin (IL)-4 and IL-13. It is approved in the U.S.A. for patients aged ≥ 12 years with moderate-to-severe atopic dermatitis (AD) uncontrolled...
2.
Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbe A, Nelson L, et al.
Br J Dermatol
. 2019 Feb;
181(4):761-769.
PMID: 30729499
Background: Moderate-to-severe atopic dermatitis (AD) is a chronic disease characterized by intense, persistent and debilitating itch, resulting in sleep deprivation, signs of anxiety and depression, impaired quality of life and...
3.
Staudinger H
Schweizer Chem Ztg Tech Ind
. 2010 Mar;
29(15):255-8.
PMID: 20276207
No abstract available.
4.
Bousquet J, Gaudano E, Palma Carlos A, Staudinger H
Allergy
. 1999 Aug;
54(6):562-8.
PMID: 10435469
This double-blind, placebo-controlled, multicentre study investigated the ability of ebastine, 10 and 20 mg once daily, to control symptoms of perennial allergic rhinitis (PAR) over a 12-week period, and assessed...
5.
Deslandes B, Lim J, Staudinger H
J Allergy Clin Immunol
. 1998 Jul;
102(1):154-5.
PMID: 9679864
No abstract available.
6.
7.
DAlonzo G, Smolensky M, Feldman S, Gianotti L, Emerson M, Staudinger H, et al.
Am Rev Respir Dis
. 1990 Jul;
142(1):84-90.
PMID: 2195936
Many patients with asthma experience a worsening of symptoms at night and in the early morning, resulting in sleep disruption and possibly altered daily performance. A bronchodilator agent that exerts...
8.
Cazzola M, DAmato G, Guidetti E, Staudinger H, Steinijans V, Kilian U
Pulm Pharmacol
. 1990 Jan;
3(4):185-9.
PMID: 2135223
The effect of an M1-selective muscarinic receptor antagonist telenzepine on lung function was investigated in 18 patients with chronic obstructive bronchitis in a double blind, placebo-controlled, randomized crossover study. FEV1,...
9.
Steinijans V, Trautmann H, Sauter R, Staudinger H
Arzneimittelforschung
. 1988 Aug;
38(8A):1251-3.
PMID: 3190814
In view of the large interindividual differences in theophylline clearance and the narrow therapeutic range it is essential to individualize the theophylline dose. In order to do so, estimation of...
10.
Steinijans V, Sauter R, Bohm A, Staudinger H
Arzneimittelforschung
. 1988 Aug;
38(8A):1241-50.
PMID: 3190813
Euphylong is a new anhydrous theophylline sustained-release pellet formulation developed for once-daily administration in the evening in normal and slow metabolizers, and unequally divided twice-daily administration in fast metabolizers. Its...